Career Enhancement Program
职业提升计划
基本信息
- 批准号:10716161
- 负责人:
- 金额:$ 8.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2026-07-31
- 项目状态:未结题
- 来源:
- 关键词:AchievementAffinityAreaAsian AmericansAwardCancer CenterClinical TrialsCollaborationsCommunitiesDevelopmentDisabled PersonsDisciplineDisparityEnsureEthnic OriginEthnic PopulationFacultyFocus GroupsFosteringFundingGoalsGrantHawaiiIncidenceIndividualInstitutionInterventionJournalsLeadershipMalignant NeoplasmsMentorsMentorshipMinorityMinority Health ResearchMonitorNative Hawaiian or Other Pacific IslanderOutcomeOutcome MeasurePacific IslandsPoliciesPopulationProceduresProcessProgram EffectivenessProgress ReportsPublicationsRaceResearchResearch PersonnelResearch SupportResourcesScientistServicesSexual and Gender MinoritiesStandardizationSystemTalentsTrainingTranslational ResearchUnderrepresented PopulationsUniversitiesVeteransWomanWorkWritingcancer health disparitycancer preventioncancer riskcancer therapycandidate selectioncareercareer developmentdesigneffectiveness evaluationethnic disparityfaculty mentorhealth care qualityimprovedinnovationmemberminority disparityminority healthminority health disparitymulti-ethnicmultidisciplinaryprogramsracial disparityracial populationsenior facultysuccess
项目摘要
SUMMARY
The University of Hawai`i Cancer Center (UHCC) SPORE Career Enhancement Program (CEP) will identify and
mentor investigators who show promise for independent research careers in translational research in minority
health and correcting ethnic/racial disparities in cancer. We understand that creating a sustained, high-impact
minority health program is dependent upon attracting the most promising investigators from a diverse talented
pool inclusive of underrepresented groups including racial/ethnic and sexual/gender minorities, women, veterans,
and individuals with disabilities, to help these faculty members excel through quality mentorship and research
support. UH Cancer Center members have access to unique opportunities in Hawai`i and the Pacific to do
innovative research in minority health and disparities research in cancer due to the multiple racial and ethnic
populations living here and their varying cancer incidence and outcomes. Further, Hawai`i's high-quality health
care and cancer registration systems offers access to needed resources for these studies. UHCC has an
extensive record of successfully working with Hawaii's multiethnic population around minority health issues and
to identify and understand disparities in various cancers. We also have a long track record of mentoring our
promising junior faculty to independent research careers with particular success among researchers from
AANHPI background. The UHCC has also been successful engaging established researchers in developing new
projects in minority health and disparities research by providing forums to disseminate and discuss ideas that
are important to cancer prevention and treatment in our catchment. The goal of the CEP is to provide funding and
mentoring to junior faculty to develop independent research programs and to provide support to established
investigators to greatly enhance or refocus their careers on minority health research. In service of this goal, we
propose the following Specific Aims: 1) Coordinate identification of promising new research in disparities
research from junior faculty and established investigators looking to refocus their research in this area; 2) Provide
training, career development and mentoring to awardees in minority health research; 3) Monitor the progress of
CEP awardees as they develop independent careers and/or new research programs in minority health, and
assess effectiveness of the CEP approach. Through these activities, we will foster development of new diverse
faculty who conducts highly collaborative translational research in minority health focusing on Asian Americans,
Native Hawaiians and Pacific Islanders aimed at understanding differences in cancer risk and outcomes and
correcting ethnic/racial disparities in Hawai`i, the Pacific Islands, and more broadly on the US and global stages.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GERTRAUD MASKARINEC其他文献
GERTRAUD MASKARINEC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GERTRAUD MASKARINEC', 18)}}的其他基金
Urinary Estrogen Metabolites in a 2-year Soy Trial Among Premenopausal Women
在绝经前妇女中进行的为期 2 年的大豆试验中的尿雌激素代谢物
- 批准号:
8034695 - 财政年份:2010
- 资助金额:
$ 8.41万 - 项目类别:
Urinary Estrogen Metabolites in a 2-year Soy Trial Among Premenopausal Women
在绝经前妇女中进行的为期 2 年的大豆试验中的尿雌激素代谢物
- 批准号:
7896351 - 财政年份:2010
- 资助金额:
$ 8.41万 - 项目类别:
A pooled analysis of mammographic density and breast cancer risk
乳房X线照相密度和乳腺癌风险的汇总分析
- 批准号:
7775049 - 财政年份:2009
- 资助金额:
$ 8.41万 - 项目类别:
A pooled analysis of mammographic density and breast cancer risk
乳房X光密度和乳腺癌风险的汇总分析
- 批准号:
7660546 - 财政年份:2009
- 资助金额:
$ 8.41万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 8.41万 - 项目类别:
Continuing Grant














{{item.name}}会员




